Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Breast Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Breast Implants includes the Sizers, Expanders, Premium round gel Implants, Round gel Implants, Saline Implants and Shaped gel Implants.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Breast Implants under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Breast Implants and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Breast Implants under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Breast Implants Overview
4 Products under Development
4.1 Breast Implants - Pipeline Products by Stage of Development
4.2 Breast Implants - Pipeline Products by Segment
4.3 Breast Implants - Pipeline Products by Territory
4.4 Breast Implants - Pipeline Products by Regulatory Path
4.5 Breast Implants - Pipeline Products by Estimated Approval Date
4.6 Breast Implants - Ongoing Clinical Trials
5 Breast Implants - Pipeline Products under Development by Companies
5.1 Breast Implants Companies - Pipeline Products by Stage of Development
5.2 Breast Implants – Companies Pipeline Products by Stage of Development
6 Breast Implants Companies and Product Overview
6.1 D Bio Corp Company Overview
6.1.1 D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview
7.1 Mar 19, 2024: The Aesthetic Society and The Aesthetic Foundation Launch ARISE-- American Registry for Breast Implant Surveillance
7.2 Jan 31, 2024: New Investigator-Initiated Clinical Trials of BellaSeno´s Resorbable Tissue Regeneration scaffolds to be Conducted in Europe
7.3 Jan 26, 2024: New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics' PERLE Breast Implant
7.4 Jan 08, 2024: Collplant’s CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
7.5 Jan 02, 2024: Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
7.6 Jan 02, 2024: Collplant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
7.7 Nov 10, 2023: PIP Breast Implants: Last Claim for Damages against TUV Rheinland in Germany Definitively Dismiss
7.8 Nov 09, 2023: Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
7.9 Oct 30, 2023: Motiva Receives 510(K) Clearance For Motiva Flora SmoothSilk Tissue Expander
7.1 Oct 26, 2023: GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
7.11 Oct 24, 2023: MTF Biologics Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction
7.12 Oct 13, 2023: Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
7.13 Sep 05, 2023: BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds
7.14 Jul 11, 2023: Sientra High-Strength Cohesive Silicone Gel Breast Implants Launch in Canada
7.15 Jun 20, 2023: BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction
7.16 Jun 08, 2023: Sientra Announces FDA-Clearance of Next Generation ALLOX2 Pro Tissue Expander
7.17 May 25, 2023: Decisions of the French Supreme Court in the PIP Breast Implant Case
7.18 May 09, 2023: Positive interim data of BellaSeno's clinical trial with resorbable breast and chest implants reported at RACS 2023
7.19 Apr 20, 2023: Establishment Labs notes presentation of 3-year results from Motiva U.S. IDE study at The Aesthetic Meeting 2023
7.2 Apr 10, 2023: Establishment Labs begins a new era in breast aesthetics with launch of Mia Femtech in Japan
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Breast Implants - Pipeline Products by Stage of Development
Table 2: Breast Implants - Pipeline Products by Segment
Table 3: Breast Implants - Pipeline Products by Territory
Table 4: Breast Implants - Pipeline Products by Regulatory Path
Table 5: Breast Implants - Pipeline Products by Estimated Approval Date
Table 6: Breast Implants - Ongoing Clinical Trials
Table 7: Breast Implants Companies - Pipeline Products by Stage of Development
Table 8: Breast Implants – Companies Pipeline Products by Stage of Development
Table 9: D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 10: D Printed Breast Implant - Lupectomy Reconstruction - Product Status
Table 11: D Printed Breast Implant - Lupectomy Reconstruction - Product Description
Table 31: Senella Scaffold - Clinical Trial Evaluating Feasibility and Safety of Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation with Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery
Table 32: D Printed Pectus Scaffold Implant - Pectus Excavatum - A Clinical Trial Evaluating Medical-Grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage
Table 33: D Printed Pectus Scaffold Implant - Pectus Excavatum - An Investigator-Initiated Clinical Trial to Evaluate the Effect of Novel Regenerative Scaffolds for Bone Reconstruction and Chest-Wall Defects (Pectus Excavatum)
Table 34: D Printed Pectus Scaffold Implant - Pectus Excavatum - Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage (IT)
Table 53: Motiva Ergonomix2 Diamond Breast Implant - Product Status
Table 54: Motiva Ergonomix2 Diamond Breast Implant - Product Description
Table 55: Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Product Status
Table 56: Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Product Description
Table 57: Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety - Product Status
Table 58: Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety - Product Description
Table 59: Motiva MIA - Product Status
Table 60: Motiva MIA - Product Description
Table 61: Motiva Round - Product Status
Table 62: Motiva Round - Product Description
Table 63: Establishment Labs SA - Ongoing Clinical Trials Overview
Table 64: Motiva Round - Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation
Table 65: Motiva Round - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
Table 66: Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
Table 67: Motiva Ergonomix - Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation
Table 68: Motiva Ergonomix - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
Table 69: Motiva Ergonomix2 - Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study
Table 70: Motiva MIA - A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants
Table 78: PERLE - A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation
Table 91: Lattice Medical - Ongoing Clinical Trials Overview
Table 92: MATTISSE - First-in-human Study of MATTISSE® Tissue Engineering Chamber in Adult Female After Total Mastectomy for Breast Cancer in Immediate or Delayed 2-stage Tissue Expander Reconstruction or Conversion From Implant-based to Autologous Reconstruction
Table 127: ESTYME MATRIX Silicone Gel-Filled Breast Implant - Evaluation of the Safety and Performance of Symatese Aesthetics Estyme Matrix Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study) 6
Table 132: REGENERA Breast Implant - A Pilot Study of REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up